Borealis was founded on the principle that great ideas and entrepreneurial talent existed in northern New England, but that access to early stage capital and experienced mentorship was lacking. We believe that this is still true. In 2012, Borealis began to deploy the Borealis Granite Fund, a pool of capital intended to nurture emerging technology companies in New Hampshire and to set the stage for their growth.
Avitide, Inc., the leader in the discovery, manufacture, and supply of novel affinity purification solutions for the biopharmaceutical industry, closed its Series D financing. Mithril Capital Management, LLC led the financing round. Avitide rapidly and [...]
Adimab LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Takeda Pharmaceutical Company Ltd. Under the terms of the agreement, Adimab will [...]
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has received approval from the U.S. Food and Drug Administration (FDA) for Photrexa Viscous, Photrexa and the KXL System. Photrexa Viscous and Photrexa are photoenhancers indicated [...]
The offices of Adimab, a biotech company in Lebanon, New Hampshire, smell pleasantly of fresh bread. It’s an olfactory illusion, albeit a welcome one. Nobody is baking anything. The laboratory is lined with beaker after [...]
"The New Hampshire Charitable Foundation is dedicated to connecting its donors with effective organizations and ideas, but also to ensuring that the assets with which it is entrusted are maximized. Our partners at Borealis map tightly to each of those dimensions of our mission: they are effective stewards of our assets, but also share our commitment to improving the communities that comprise the state."
New Hampshire Charitable Foundation
We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.